169 related articles for article (PubMed ID: 24629097)
21. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer.
Dahan L; Norguet E; Etienne-Grimaldi MC; Formento JL; Gasmi M; Nanni I; Gaudart J; Garcia S; Ouafik L; Seitz JF; Milano G
BMC Cancer; 2011 Nov; 11():496. PubMed ID: 22117530
[TBL] [Abstract][Full Text] [Related]
23. EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissues.
Zhou Q; Cheung YB; Jada SR; Lim WT; Kuo WL; Gray JW; Lee AS; Chowbay B
Cancer Biol Ther; 2006 Nov; 5(11):1445-9. PubMed ID: 17102595
[TBL] [Abstract][Full Text] [Related]
24. Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.
Vieira-Monteiro Hde A; Freitas-Alves DR; Sobral-Leite M; Delou JM; Goulart-Citrangulo SM; do Nascimento CT; E Castro TN; Koifman S; Perini JA; Vianna-Jorge R
Cancer Biol Ther; 2016 Jun; 17(6):674-83. PubMed ID: 27195611
[TBL] [Abstract][Full Text] [Related]
25. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
[TBL] [Abstract][Full Text] [Related]
27. Association of the EGFR intron 1 CA repeat length with lung cancer risk.
Zhang W; Weissfeld JL; Romkes M; Land SR; Grandis JR; Siegfried JM
Mol Carcinog; 2007 May; 46(5):372-80. PubMed ID: 17219440
[TBL] [Abstract][Full Text] [Related]
28. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population.
He BS; Xu T; Pan YQ; Wang HJ; Cho WC; Lin K; Sun HL; Gao TY; Wang SK
Oncotarget; 2016 Dec; 7(51):84872-84882. PubMed ID: 27768589
[TBL] [Abstract][Full Text] [Related]
30. Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro.
Puyo S; Le Morvan V; Robert J
Mol Diagn Ther; 2008; 12(4):225-34. PubMed ID: 18652519
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
33. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
[TBL] [Abstract][Full Text] [Related]
34. Study of p53 codon 72 polymorphism in patients with breast cancer.
Vieira JO; da Silva ID; Higo PE; Nogueira-de-Souza NC; Gebrim LH
Eur J Gynaecol Oncol; 2008; 29(4):364-7. PubMed ID: 18714570
[TBL] [Abstract][Full Text] [Related]
35. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
36. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.
Ishitobi M; Miyoshi Y; Ando A; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
Clin Cancer Res; 2003 Apr; 9(4):1376-80. PubMed ID: 12684407
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite profile in hormonal receptor genes associated with breast cancer.
Iobagiu C; Lambert C; Normand M; Genin C
Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584
[TBL] [Abstract][Full Text] [Related]
38. Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.
Kharrat N; Al'Fadhli S; Rebaï A
J Recept Signal Transduct Res; 2008; 28(5):475-83. PubMed ID: 18946768
[TBL] [Abstract][Full Text] [Related]
39. Lack of evidence for prognostic value of epidermal growth factor receptor intron-1 CA repeats for oral carcinomas.
Precht C; Blessmann M; Kluwe L; Scheld T; Schön G; Henningsen A; Pflug C; Smeets R; Heiland M; Gröbe A
Eur J Oral Sci; 2017 Apr; 125(2):95-101. PubMed ID: 28150908
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
